Jeanne Eagels

ARCHER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Archer Aviation, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, October 3, 2023
Class Action Lawsuit, Professional Services, Legal, P.C, Loss, Aviation, Telephone, Jeanne Eagels, Person, Certification, FAA, District court, Nature, Court, Archery

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Archer Aviation, Inc. (“Archer” or the “Company”) (NASDAQ: ACHR) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Archer securities between September 17, 2021 and August 15, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Archer Aviation, Inc. (“Archer” or the “Company”) (NASDAQ: ACHR) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Archer securities between September 17, 2021 and August 15, 2023, both dates inclusive (the “Class Period”).
  • Investors have until November 20, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.

DOCGO ALERT: Bragar Eagel & Squire, P.C. is Investigating DocGo, Inc. on Behalf of DocGo Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, October 3, 2023
Class Action Lawsuit, Professional Services, Legal, Telephone, P.C, The New York Times, Jeanne Eagels, Albany Devils, News, Frustration, Cryptocurrency

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against DocGo, Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) on behalf of DocGo stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against DocGo, Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) on behalf of DocGo stockholders.
  • Our investigation concerns whether DocGo has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On July 30, 2023, the New York Times published an article reporting on a "rocky" start to DocGo's migrant relocation efforts in New York City.
  • On the following day, September 15, 2023, DocGo disclosed Capone's resignation as CEO in a filing with the U.S. Securities and Exchange Commission.

SOTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Sotera Health Co. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Class Action Lawsuit, Professional Services, Legal, Pressure, P.C, Poison, IPO, JPMorgan Chase, Human, Probability, Office of Inspector General, U.S. Department of Health and Human Services, Atmosphere, GTCR, Culture, Telephone, Human services, Offerings, Class, NATA, Cancer, Jeanne Eagels, SHC, SPO, Sterilization, Goldman Sachs, EPA, School, Risk, Agency, Warburg Pincus, Ethylene oxide, Knowledge, Health, News, Safety, Cryptocurrency, Dietary supplement, Environmental remediation, Tobacco, Pharmaceutical industry, Nordion, Sotera Tschetter

Our investigation concerns whether the board of directors of Sotera have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Sotera have breached their fiduciary duties to the company.
  • Sotera provides sterilization and lab testing and advisory services to the medical device and pharmaceutical industries.
  • The Company’s sterilization services rely on three primary technologies, one of which is Ethylene Oxide (“EtO”) processing.
  • Sotera, through its Sterigenics business, conducts or has conducted EtO processing at facilities located in Illinois, California, Georgia, and New Mexico.

PARTY CITY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Party City Holdco, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Class Action Lawsuit, Professional Services, Legal, P.C, LLP, Chapter 11, Title 11, United States Code, Telephone, Jeanne Eagels, Person, District court, OTC, Court, News, Ernst & Young, Security (finance), Party City

Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • After trading on January 17, 2023, Party City filed for bankruptcy protection under Chapter 11.
  • Following this news, Party City's stock price declined by 22% over the next three trading days from a closing price of $0.046 on June 9, 2023 to $0.036 on June 14, 2023.

LIVE NATION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Live Nation Entertainment, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Class Action Lawsuit, Professional Services, Legal, Ticketmaster, Pressure, P.C, Music, Senate, Central District, Politico, Telephone, Consumer, DOJ, LYV, Jeanne Eagels, United States Senate Judiciary Subcommittee on Competition Policy, Antitrust and Consumer Rights, Live Nation Entertainment, Person, Competition law, District court, Congress, The New York Times, NPR, Court, Knowledge, Defendant, Policy, Letter, News, NYSE, Cryptocurrency

Investors have until October 3, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 3, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On November 18, 2022, The New York Times reported that the DOJ had opened an antitrust investigation into Ticketmaster and Live Nation after the ticketing platform’s systems crashed during a highly-anticipated presale for Taylor Swift tickets.
  • The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

RTX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against RTX Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Class Action Lawsuit, Professional Services, Legal, Telephone, P.C, Court, GTF, Jeanne Eagels, District court, News, NYSE, RTX, Person, Security (finance)

Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On this news, the price of RTX shares declined by more than 10%, damaging investors.
  • There is no cost or obligation to you.

VERIZON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Verizon Communications, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Class Action Lawsuit, Professional Services, Legal, AT&T, P.C, AT, The Wall Street Journal, VZ, Telephone, Lead, Jeanne Eagels, Person, District court, Soil, Groundwater, Verizon Communications, Court, News, NYSE, Safety

Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • In a related article, the Wall Street Journal estimated that cleanup costs could run into the tens of billions of dollars.
  • Following this news, Verizon stock dropped $2.55 per share, or 7.5%, to close at $31.46 on July 17, 2023.
  • When the true details entered the market, the lawsuit claims that investors suffered damages.

HAYWARD DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Hayward Holdings, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Class Action Lawsuit, Professional Services, Legal, P.C, Telephone, Jeanne Eagels, Person, District court, III, Court, Security (finance), Cryptocurrency, Hayward

Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • As a result, Hayward Holdings reduced its 2022 guidance to reflect massive inventory reduction in the second half of the year.
  • As a result, the price of Hayward Holdings common stock fell nearly 24%, damaging investors.

APELLIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Apellis Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 30, 2023
Legal, Professional Services, Retinal scan, Retina, Injection, P.C, Autoimmunity, APLS, Telephone, Retinal vasculitis, Clinical trial, Geographic atrophy, Jeanne Eagels, Vasculitis, Paratriathlon, Risk, GA, Inflammation, Person, First, Wedbush Securities, District court, Patient, Physician, Complaint, Court, Regulation of tobacco by the U.S. Food and Drug Administration, Society, News, Food, ASRS, Safety, Pharmaceutical industry

Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 2, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Apellis is a commercial-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases.
  • SYFOVRE is designed to provide comprehensive control of the complement cascade, part of the body’s immune system.
  • Apellis also stated that the company is evaluating an eighth reported event of retinal vasculitis, which Apellis had not yet confirmed.

ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Acelyrin Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, September 29, 2023
Class Action Lawsuit, Professional Services, Legal, Telephone, P.C, SLRN, Jeanne Eagels, IPO, Patient, News, Part, Abscess, Pharmaceutical industry

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Acelyrin, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) on behalf of Acelyrin stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Acelyrin, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) on behalf of Acelyrin stockholders.
  • Our investigation concerns whether Acelyrin has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On or around May 5, 2023, Acelyrin conducted its initial public offering ("IPO"), selling 30 million shares of common stock priced at $18.00 per share.
  • Specifically, izokibep failed to show statistically significant reduction in abscesses and inflammatory nodules in patients as compared to placebo.